EMA Consults On Extrapolation Considerations For Antibacterial Agents To Treat Pediatrics
Draft guidance from the European Medicines Agency explains what data companies should generate when they seek marketing approval for antibacterial agents for treating children, including whether pharmacokinetic data in a limited number of pediatric subjects may be suffice to grant a pediatric indication.
You may also be interested in...
Following a resurgence of activity in the field of antibacterial products, the European Medicines Agency has proposed merging and updating its two existing guidelines on this topic into a single, clearer, core document.
Device companies operating in Canada are being advised to review their internal procedures in anticipation of new postmarket requirements that come into force this year.
Remote inspections are here to stay, and global regulators are aligning efforts to develop consensus on how these should be conducted.